Essential techniques for successful radio-frequency thermal ablation of malignant hepatic tumors

被引:254
作者
Rhim, H
Goldbert, SN
Dodd, GD
Solbiati, L
Lim, HK
Tonolini, M
Cho, OK
机构
[1] Hanyang Univ Hosp, Dept Diagnost Radiol, Sungdong Ku, Seoul 133792, South Korea
[2] Beth Israel Deaconess Med Ctr, Dept Radiol, Boston, MA 02215 USA
[3] Univ Texas, Hlth Sci Ctr, Dept Radiol, San Antonio, TX 78284 USA
[4] Osped Gen, Dept Radiol, Busto Arsizio, Italy
[5] Samsung Med Ctr, Dept Radiol, Seoul, South Korea
关键词
interventional prodecures; technology; liver; interventional procedure; liver neoplasms; therapy; radiofrequency (RF) ablation;
D O I
10.1148/radiographics.21.suppl_1.g01oc11s17
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Radio-frequency thermal ablation is one of the most promising minimally invasive techniques for the treatment of nonresectable hepatic tumors. Essential technical tips to successful radio-frequency ablation therapy were collected from five international experts. They were organized into five categories: understanding the mechanisms and principles of radio-frequency ablation, modulation of tissue physiologic characteristics to increase tumor destruction, strategies of overlapping ablations, strategies to improve ablation according to tumor location, and imaging strategies after ablation to ensure adequate therapy. Established factors for optimal ablation, as well as emerging technical tips, are addressed with illustrations in each section. These essential tips will be very helpful for physicians performing radio-frequency ablation of hepatic tumors.
引用
收藏
页码:S17 / S35
页数:19
相关论文
共 56 条
[1]  
Akhurst T, 1999, SEMIN ONCOL, V26, P577
[2]   Hepatocellular carcinoma treatment with percutaneous ethanol injection: Evaluation with contrast-enhanced color Doppler US [J].
Bartolozzi, C ;
Lencioni, R ;
Ricci, P ;
Paolicchi, A ;
Rossi, P ;
Passariello, R .
RADIOLOGY, 1998, 209 (02) :387-393
[3]  
Burns PN, 1996, CLIN RADIOL, V51, P50
[4]   Surgical margin in hepatic resection for colorectal metastasis - A critical and improvable determinant of outcome [J].
Cady, B ;
Jenkins, RL ;
Steele, GD ;
Lewis, WD ;
Stone, MD ;
McDermott, WV ;
Jessup, JM ;
Bothe, A ;
Lalor, P ;
Lovett, EJ ;
Lavin, P ;
Linehan, DC .
ANNALS OF SURGERY, 1998, 227 (04) :566-571
[5]   Hepatocellular carcinoma treated with percutaneous radio-frequency ablation: Usefulness of power Doppler US with a microbubble contrast agent in evaluating therapeutic response-preliminary results [J].
Choi, D ;
Lim, HK ;
Kim, SH ;
Lee, WJ ;
Jang, HJ ;
Lee, JY ;
Paik, SW ;
Koh, KC ;
Lee, JH .
RADIOLOGY, 2000, 217 (02) :558-563
[6]   Contrast-enhanced subtraction harmonic sonography for evaluating treatment response in patients with hepatocellular carcinoma [J].
Ding, H ;
Kudo, M ;
Onda, H ;
Suetomi, Y ;
Minami, Y ;
Maekawa, K .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2001, 176 (03) :661-666
[7]   Minimally invasive treatment of malignant hepatic tumors: At the threshold of a major breakthrough [J].
Dodd, GD ;
Soulen, MC ;
Kane, RA ;
Livraghi, T ;
Lees, WR ;
Yamashita, Y ;
Gillams, AR ;
Karahan, OI ;
Rhim, H .
RADIOGRAPHICS, 2000, 20 (01) :9-27
[8]  
Dromain C, 1999, RADIOLOGY, V213P, P382
[9]   CURRENT TREATMENT MODALITIES FOR HEPATOCELLULAR-CARCINOMA [J].
FARMER, DG ;
ROSOVE, MH ;
SHAKED, A ;
BUSUTTIL, RW .
ANNALS OF SURGERY, 1994, 219 (03) :236-247
[10]  
Fong Y, 1996, SEMIN SURG ONCOL, V12, P219, DOI 10.1002/(SICI)1098-2388(199607/08)12:4<219::AID-SSU3>3.3.CO